Anti-CD19 U-CAR-T Cell Therapy for B Cell Hematologic Malignancies
Clinical trial NCT04264039 · UNKNOWN
Trial details
- NCT number
- NCT04264039
- Sponsor
- Xinqiao Hospital of Chongqing
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-01
- Primary completion
- 2021-04-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.